1 Study Coverage 1.1 Lexapro Product Introduction 1.2 Market by Type 1.2.1 Global Lexapro Market Size Growth Rate by Type 1.2.2 Tablets 1.2.3 Solution 1.3 Market by Application 1.3.1 Global Lexapro Market Size Growth Rate by Application 1.3.2 Children 1.3.3 Adults 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Lexapro Market Size, Estimates and Forecasts 2.1.1 Global Lexapro Revenue 2016-2027 2.1.2 Global Lexapro Sales 2016-2027 2.2 Global Lexapro, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Lexapro Historical Market Size by Region (2016-2021) 2.3.1 Global Lexapro Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Lexapro Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Lexapro Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Lexapro Sales Forecast by Region (2022-2027) 2.4.2 Global Lexapro Revenue Forecast by Region (2022-2027) 3 Global Lexapro Competitor Landscape by Players 3.1 Global Top Lexapro Manufacturers by Sales 3.1.1 Global Lexapro Sales by Manufacturer (2016-2021) 3.1.2 Global Lexapro Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Lexapro Manufacturers by Revenue 3.2.1 Key Lexapro Manufacturers Covered: Ranking by Revenue 3.2.2 Global Lexapro Revenue by Manufacturers (2016-2021) 3.2.3 Global Lexapro Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Lexapro Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Lexapro Revenue in 2020 3.2.6 Global Lexapro Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Lexapro Price by Manufacturers 3.4 Global Lexapro Manufacturing Base Distribution, Product Types 3.4.1 Lexapro Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Lexapro Product Type 3.4.3 Date of International Manufacturers Enter into Lexapro Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Lexapro Market Size by Type (2016-2021) 4.1.1 Global Lexapro Sales by Type (2016-2021) 4.1.2 Global Lexapro Revenue by Type (2016-2021) 4.1.3 Lexapro Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Lexapro Market Size Forecast by Type (2022-2027) 4.2.1 Global Lexapro Sales Forecast by Type (2022-2027) 4.2.2 Global Lexapro Revenue Forecast by Type (2022-2027) 4.2.3 Lexapro Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Lexapro Market Size by Application (2016-2021) 5.1.1 Global Lexapro Sales by Application (2016-2021) 5.1.2 Global Lexapro Revenue by Application (2016-2021) 5.1.3 Lexapro Price by Application (2016-2021) 5.2 Lexapro Market Size Forecast by Application (2022-2027) 5.2.1 Global Lexapro Sales Forecast by Application (2022-2027) 5.2.2 Global Lexapro Revenue Forecast by Application (2022-2027) 5.2.3 Global Lexapro Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Lexapro Market Size YoY Growth 2016-2027 6.1.1 Japan Lexapro Sales YoY Growth 2016-2027 6.1.2 Japan Lexapro Revenue YoY Growth 2016-2027 6.1.3 Japan Lexapro Market Share in Global Market 2016-2027 6.2 Japan Lexapro Market Size by Players (International and Local Players) 6.2.1 Japan Top Lexapro Players by Sales (2016-2021) 6.2.2 Japan Top Lexapro Players by Revenue (2016-2021) 6.3 Japan Lexapro Historic Market Review by Type (2016-2021) 6.3.1 Japan Lexapro Sales Market Share by Type (2016-2021) 6.3.2 Japan Lexapro Revenue Market Share by Type (2016-2021) 6.3.3 Japan Lexapro Price by Type (2016-2021) 6.4 Japan Lexapro Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Lexapro Sales Forecast by Type (2022-2027) 6.4.2 Japan Lexapro Revenue Forecast by Type (2022-2027) 6.4.3 Japan Lexapro Price Forecast by Type (2022-2027) 6.5 Japan Lexapro Historic Market Review by Application (2016-2021) 6.5.1 Japan Lexapro Sales Market Share by Application (2016-2021) 6.5.2 Japan Lexapro Revenue Market Share by Application (2016-2021) 6.5.3 Japan Lexapro Price by Application (2016-2021) 6.6 Japan Lexapro Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Lexapro Sales Forecast by Application (2022-2027) 6.6.2 Japan Lexapro Revenue Forecast by Application (2022-2027) 6.6.3 Japan Lexapro Price Forecast by Application (2022-2027) 7 North America 7.1 North America Lexapro Market Size YoY Growth 2016-2027 7.2 North America Lexapro Market Facts & Figures by Country 7.2.1 North America Lexapro Sales by Country (2016-2021) 7.2.2 North America Lexapro Revenue by Country (2016-2021) 7.2.3 United States 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Lexapro Market Size YoY Growth 2016-2027 8.2 Asia Pacific Lexapro Market Facts & Figures by Region 8.2.1 Asia Pacific Lexapro Sales by Region (2016-2021) 8.2.2 Asia Pacific Lexapro Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 9 Europe 9.1 Europe Lexapro Market Size YoY Growth 2016-2027 9.2 Europe Lexapro Market Facts & Figures by Country 9.2.1 Europe Lexapro Sales by Country (2016-2021) 9.2.2 Europe Lexapro Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Lexapro Market Size YoY Growth 2016-2027 10.2 Latin America Lexapro Market Facts & Figures by Country 10.2.1 Latin America Lexapro Sales by Country (2016-2021) 10.2.2 Latin America Lexapro Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Lexapro Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Lexapro Market Facts & Figures by Country 11.2.1 Middle East and Africa Lexapro Sales by Country (2016-2021) 11.2.2 Middle East and Africa Lexapro Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Lundbeck (DK) 12.1.1 Lundbeck (DK) Corporation Information 12.1.2 Lundbeck (DK) Description and Business Overview 12.1.3 Lundbeck (DK) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Lundbeck (DK) Lexapro Products Offered 12.1.5 Lundbeck (DK) Recent Development 12.2 Amneal Pharmaceuticals (US) 12.2.1 Amneal Pharmaceuticals (US) Corporation Information 12.2.2 Amneal Pharmaceuticals (US) Description and Business Overview 12.2.3 Amneal Pharmaceuticals (US) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Amneal Pharmaceuticals (US) Lexapro Products Offered 12.2.5 Amneal Pharmaceuticals (US) Recent Development 12.3 Forest Laboratories (US) 12.3.1 Forest Laboratories (US) Corporation Information 12.3.2 Forest Laboratories (US) Description and Business Overview 12.3.3 Forest Laboratories (US) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Forest Laboratories (US) Lexapro Products Offered 12.3.5 Forest Laboratories (US) Recent Development 12.4 TEVA (Israel) 12.4.1 TEVA (Israel) Corporation Information 12.4.2 TEVA (Israel) Description and Business Overview 12.4.3 TEVA (Israel) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.4.4 TEVA (Israel) Lexapro Products Offered 12.4.5 TEVA (Israel) Recent Development 12.5 Mylan (US) 12.5.1 Mylan (US) Corporation Information 12.5.2 Mylan (US) Description and Business Overview 12.5.3 Mylan (US) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Mylan (US) Lexapro Products Offered 12.5.5 Mylan (US) Recent Development 12.6 Silarx Pharmacueticals (US) 12.6.1 Silarx Pharmacueticals (US) Corporation Information 12.6.2 Silarx Pharmacueticals (US) Description and Business Overview 12.6.3 Silarx Pharmacueticals (US) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Silarx Pharmacueticals (US) Lexapro Products Offered 12.6.5 Silarx Pharmacueticals (US) Recent Development 12.7 Apotex (CA) 12.7.1 Apotex (CA) Corporation Information 12.7.2 Apotex (CA) Description and Business Overview 12.7.3 Apotex (CA) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Apotex (CA) Lexapro Products Offered 12.7.5 Apotex (CA) Recent Development 12.8 Lupin (IN) 12.8.1 Lupin (IN) Corporation Information 12.8.2 Lupin (IN) Description and Business Overview 12.8.3 Lupin (IN) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Lupin (IN) Lexapro Products Offered 12.8.5 Lupin (IN) Recent Development 12.9 Novartis (US) 12.9.1 Novartis (US) Corporation Information 12.9.2 Novartis (US) Description and Business Overview 12.9.3 Novartis (US) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Novartis (US) Lexapro Products Offered 12.9.5 Novartis (US) Recent Development 12.10 Hikma Pharmaceuticals (UK) 12.10.1 Hikma Pharmaceuticals (UK) Corporation Information 12.10.2 Hikma Pharmaceuticals (UK) Description and Business Overview 12.10.3 Hikma Pharmaceuticals (UK) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Hikma Pharmaceuticals (UK) Lexapro Products Offered 12.10.5 Hikma Pharmaceuticals (UK) Recent Development 12.11 Lundbeck (DK) 12.11.1 Lundbeck (DK) Corporation Information 12.11.2 Lundbeck (DK) Description and Business Overview 12.11.3 Lundbeck (DK) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Lundbeck (DK) Lexapro Products Offered 12.11.5 Lundbeck (DK) Recent Development 12.12 Hetero Drugs (IN) 12.12.1 Hetero Drugs (IN) Corporation Information 12.12.2 Hetero Drugs (IN) Description and Business Overview 12.12.3 Hetero Drugs (IN) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Hetero Drugs (IN) Products Offered 12.12.5 Hetero Drugs (IN) Recent Development 12.13 Accord Healthcare (IN) 12.13.1 Accord Healthcare (IN) Corporation Information 12.13.2 Accord Healthcare (IN) Description and Business Overview 12.13.3 Accord Healthcare (IN) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Accord Healthcare (IN) Products Offered 12.13.5 Accord Healthcare (IN) Recent Development 12.14 Macleods Pharmaceuticals (IN) 12.14.1 Macleods Pharmaceuticals (IN) Corporation Information 12.14.2 Macleods Pharmaceuticals (IN) Description and Business Overview 12.14.3 Macleods Pharmaceuticals (IN) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Macleods Pharmaceuticals (IN) Products Offered 12.14.5 Macleods Pharmaceuticals (IN) Recent Development 12.15 Xian Janssen Pharmaceutical (CN) 12.15.1 Xian Janssen Pharmaceutical (CN) Corporation Information 12.15.2 Xian Janssen Pharmaceutical (CN) Description and Business Overview 12.15.3 Xian Janssen Pharmaceutical (CN) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Xian Janssen Pharmaceutical (CN) Products Offered 12.15.5 Xian Janssen Pharmaceutical (CN) Recent Development 12.16 Jewim Pharmaceutical (Shandong) 12.16.1 Jewim Pharmaceutical (Shandong) Corporation Information 12.16.2 Jewim Pharmaceutical (Shandong) Description and Business Overview 12.16.3 Jewim Pharmaceutical (Shandong) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Jewim Pharmaceutical (Shandong) Products Offered 12.16.5 Jewim Pharmaceutical (Shandong) Recent Development 12.17 Sichuan Kelun Pharmaceutical (CN) 12.17.1 Sichuan Kelun Pharmaceutical (CN) Corporation Information 12.17.2 Sichuan Kelun Pharmaceutical (CN) Description and Business Overview 12.17.3 Sichuan Kelun Pharmaceutical (CN) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Sichuan Kelun Pharmaceutical (CN) Products Offered 12.17.5 Sichuan Kelun Pharmaceutical (CN) Recent Development 12.18 Hunan Dongting Pharmaceutical (CN) 12.18.1 Hunan Dongting Pharmaceutical (CN) Corporation Information 12.18.2 Hunan Dongting Pharmaceutical (CN) Description and Business Overview 12.18.3 Hunan Dongting Pharmaceutical (CN) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Hunan Dongting Pharmaceutical (CN) Products Offered 12.18.5 Hunan Dongting Pharmaceutical (CN) Recent Development 12.19 Zhejiang Conba Pharmaceutical (CN) 12.19.1 Zhejiang Conba Pharmaceutical (CN) Corporation Information 12.19.2 Zhejiang Conba Pharmaceutical (CN) Description and Business Overview 12.19.3 Zhejiang Conba Pharmaceutical (CN) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Zhejiang Conba Pharmaceutical (CN) Products Offered 12.19.5 Zhejiang Conba Pharmaceutical (CN) Recent Development 12.20 Xidian Pharmaceutical (CN) 12.20.1 Xidian Pharmaceutical (CN) Corporation Information 12.20.2 Xidian Pharmaceutical (CN) Description and Business Overview 12.20.3 Xidian Pharmaceutical (CN) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Xidian Pharmaceutical (CN) Products Offered 12.20.5 Xidian Pharmaceutical (CN) Recent Development 12.21 Zhejiang Huahai Pharmaceutical (CN) 12.21.1 Zhejiang Huahai Pharmaceutical (CN) Corporation Information 12.21.2 Zhejiang Huahai Pharmaceutical (CN) Description and Business Overview 12.21.3 Zhejiang Huahai Pharmaceutical (CN) Lexapro Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Zhejiang Huahai Pharmaceutical (CN) Products Offered 12.21.5 Zhejiang Huahai Pharmaceutical (CN) Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Lexapro Industry Trends 13.2 Lexapro Market Drivers 13.3 Lexapro Market Challenges 13.4 Lexapro Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Lexapro Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Lexapro Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Tablets Table 3. Major Manufacturers of Solution Table 4. Global Lexapro Market Size Growth Rate by Application (2021-2027) & (K Units) Table 5. Global Lexapro Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Lexapro Sales by Regions (2016-2021) & (K Units) Table 7. Global Lexapro Sales Market Share by Regions (2016-2021) Table 8. Global Lexapro Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Lexapro Sales Forecast by Region (2022-2027) & (K Units) Table 10. Global Lexapro Sales Market Share Forecast by Region (2022-2027) Table 11. Global Lexapro Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Lexapro Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Lexapro Sales by Manufacturers (2016-2021) (K Units) Table 14. Global Lexapro Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Lexapro Manufacturers by Revenue (US$ Million) in 2020 Table 16. Lexapro Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Lexapro Revenue Share by Manufacturers (2016-2021) Table 18. Global Lexapro Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Lexapro by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lexapro as of 2020) Table 20. Key Manufacturers Lexapro Price (2016-2021) (US$/Unit) Table 21. Lexapro Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Lexapro Product Type Table 23. Date of International Manufacturers Enter into Lexapro Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Lexapro Sales by Type (2016-2021) (K Units) Table 26. Global Lexapro Sales Share by Type (2016-2021) Table 27. Global Lexapro Revenue by Type (2016-2021) (US$ Million) Table 28. Global Lexapro Revenue Share by Type (2016-2021) Table 29. Lexapro Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 30. Global Lexapro Sales Forecast by Type (2022-2027) & (K Units) Table 31. Global Lexapro Sales Market Share Forecast by Type (2022-2027) Table 32. Global Lexapro Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Lexapro Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Lexapro Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 35. Global Lexapro Sales by Application (2016-2021) (K Units) Table 36. Global Lexapro Sales Share by Application (2016-2021) Table 37. Global Lexapro Revenue by Application (2016-2021) (US$ Million) Table 38. Global Lexapro Revenue Share by Application (2016-2021) Table 39. Lexapro Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 40. Global Lexapro Sales Forecast by Application (2022-2027) & (K Units) Table 41. Global Lexapro Sales Market Share Forecast by Application (2022-2027) Table 42. Global Lexapro Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Lexapro Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Lexapro Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 45. Japan Lexapro Sales (K Units) of Key Companies (2016-2021) Table 46. Japan Lexapro Sales Share by Company (2016-2021) Table 47. Japan Lexapro Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Lexapro Revenue Share by Company (2016-2021) Table 49. Japan Lexapro Sales (K Units) by Type (2016-2021) Table 50. Japan Lexapro Sales Share by Type (2016-2021) Table 51. Japan Lexapro Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Lexapro Price (US$/Unit) by Type (2016-2021) Table 53. Japan Lexapro Sales (K Units) by Type (2022-2027) Table 54. Japan Lexapro Sales Share by Type (2022-2027) Table 55. Japan Lexapro Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Lexapro Revenue Share by Type (2022-2027) Table 57. Japan Lexapro Price (US$/Unit) by Type (2022-2027) Table 58. Japan Lexapro Sales (K Units) by Application (2016-2021) Table 59. Japan Lexapro Sales Share by Application (2016-2021) Table 60. Japan Lexapro Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Lexapro Price (US$/Unit) by Application (2016-2021) Table 62. Japan Lexapro Sales (K Units) by Application (2022-2027) Table 63. Japan Lexapro Sales Share by Application (2022-2027) Table 64. Japan Lexapro Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Lexapro Revenue Share by Application (2022-2027) Table 66. Japan Lexapro Price (US$/Unit) by Application (2022-2027) Table 67. North America Lexapro Sales by Country (2016-2021) & (K Units) Table 68. North America Lexapro Sales Market Share by Country (2016-2021) Table 69. North America Lexapro Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Lexapro Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Lexapro Sales by Region (2016-2021) & (K Units) Table 72. Asia Pacific Lexapro Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Lexapro Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Lexapro Revenue Market Share by Region (2016-2021) Table 75. Europe Lexapro Sales by Country (2016-2021) & (K Units) Table 76. Europe Lexapro Sales Market Share by Country (2016-2021) Table 77. Europe Lexapro Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Lexapro Revenue Market Share by Country (2016-2021) Table 79. Latin America Lexapro Sales by Country (2016-2021) & (K Units) Table 80. Latin America Lexapro Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Lexapro Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Lexapro Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Lexapro Sales by Country (2016-2021) & (K Units) Table 84. Middle East and Africa Lexapro Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Lexapro Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Lexapro Revenue Market Share by Country (2016-2021) Table 87. Lundbeck (DK) Corporation Information Table 88. Lundbeck (DK) Description and Business Overview Table 89. Lundbeck (DK) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 90. Lundbeck (DK) Lexapro Product Table 91. Lundbeck (DK) Recent Development Table 92. Amneal Pharmaceuticals (US) Corporation Information Table 93. Amneal Pharmaceuticals (US) Description and Business Overview Table 94. Amneal Pharmaceuticals (US) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 95. Amneal Pharmaceuticals (US) Product Table 96. Amneal Pharmaceuticals (US) Recent Development Table 97. Forest Laboratories (US) Corporation Information Table 98. Forest Laboratories (US) Description and Business Overview Table 99. Forest Laboratories (US) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 100. Forest Laboratories (US) Product Table 101. Forest Laboratories (US) Recent Development Table 102. TEVA (Israel) Corporation Information Table 103. TEVA (Israel) Description and Business Overview Table 104. TEVA (Israel) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 105. TEVA (Israel) Product Table 106. TEVA (Israel) Recent Development Table 107. Mylan (US) Corporation Information Table 108. Mylan (US) Description and Business Overview Table 109. Mylan (US) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 110. Mylan (US) Product Table 111. Mylan (US) Recent Development Table 112. Silarx Pharmacueticals (US) Corporation Information Table 113. Silarx Pharmacueticals (US) Description and Business Overview Table 114. Silarx Pharmacueticals (US) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. Silarx Pharmacueticals (US) Product Table 116. Silarx Pharmacueticals (US) Recent Development Table 117. Apotex (CA) Corporation Information Table 118. Apotex (CA) Description and Business Overview Table 119. Apotex (CA) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. Apotex (CA) Product Table 121. Apotex (CA) Recent Development Table 122. Lupin (IN) Corporation Information Table 123. Lupin (IN) Description and Business Overview Table 124. Lupin (IN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 125. Lupin (IN) Product Table 126. Lupin (IN) Recent Development Table 127. Novartis (US) Corporation Information Table 128. Novartis (US) Description and Business Overview Table 129. Novartis (US) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 130. Novartis (US) Product Table 131. Novartis (US) Recent Development Table 132. Hikma Pharmaceuticals (UK) Corporation Information Table 133. Hikma Pharmaceuticals (UK) Description and Business Overview Table 134. Hikma Pharmaceuticals (UK) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 135. Hikma Pharmaceuticals (UK) Product Table 136. Hikma Pharmaceuticals (UK) Recent Development Table 137. Aurobindo Pharma (IN) Corporation Information Table 138. Aurobindo Pharma (IN) Description and Business Overview Table 139. Aurobindo Pharma (IN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 140. Aurobindo Pharma (IN) Product Table 141. Aurobindo Pharma (IN) Recent Development Table 142. Hetero Drugs (IN) Corporation Information Table 143. Hetero Drugs (IN) Description and Business Overview Table 144. Hetero Drugs (IN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 145. Hetero Drugs (IN) Product Table 146. Hetero Drugs (IN) Recent Development Table 147. Accord Healthcare (IN) Corporation Information Table 148. Accord Healthcare (IN) Description and Business Overview Table 149. Accord Healthcare (IN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 150. Accord Healthcare (IN) Product Table 151. Accord Healthcare (IN) Recent Development Table 152. Macleods Pharmaceuticals (IN) Corporation Information Table 153. Macleods Pharmaceuticals (IN) Description and Business Overview Table 154. Macleods Pharmaceuticals (IN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 155. Macleods Pharmaceuticals (IN) Product Table 156. Macleods Pharmaceuticals (IN) Recent Development Table 157. Xian Janssen Pharmaceutical (CN) Corporation Information Table 158. Xian Janssen Pharmaceutical (CN) Description and Business Overview Table 159. Xian Janssen Pharmaceutical (CN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 160. Xian Janssen Pharmaceutical (CN) Product Table 161. Xian Janssen Pharmaceutical (CN) Recent Development Table 162. Jewim Pharmaceutical (Shandong) Corporation Information Table 163. Jewim Pharmaceutical (Shandong) Description and Business Overview Table 164. Jewim Pharmaceutical (Shandong) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 165. Jewim Pharmaceutical (Shandong) Product Table 166. Jewim Pharmaceutical (Shandong) Recent Development Table 167. Sichuan Kelun Pharmaceutical (CN) Corporation Information Table 168. Sichuan Kelun Pharmaceutical (CN) Description and Business Overview Table 169. Sichuan Kelun Pharmaceutical (CN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 170. Sichuan Kelun Pharmaceutical (CN) Product Table 171. Sichuan Kelun Pharmaceutical (CN) Recent Development Table 172. Hunan Dongting Pharmaceutical (CN) Corporation Information Table 173. Hunan Dongting Pharmaceutical (CN) Description and Business Overview Table 174. Hunan Dongting Pharmaceutical (CN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 175. Hunan Dongting Pharmaceutical (CN) Product Table 176. Hunan Dongting Pharmaceutical (CN) Recent Development Table 177. Zhejiang Conba Pharmaceutical (CN) Corporation Information Table 178. Zhejiang Conba Pharmaceutical (CN) Description and Business Overview Table 179. Zhejiang Conba Pharmaceutical (CN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 180. Zhejiang Conba Pharmaceutical (CN) Product Table 181. Zhejiang Conba Pharmaceutical (CN) Recent Development Table 182. Xidian Pharmaceutical (CN) Corporation Information Table 183. Xidian Pharmaceutical (CN) Description and Business Overview Table 184. Xidian Pharmaceutical (CN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 185. Xidian Pharmaceutical (CN) Product Table 186. Xidian Pharmaceutical (CN) Recent Development Table 187. Zhejiang Huahai Pharmaceutical (CN) Corporation Information Table 188. Zhejiang Huahai Pharmaceutical (CN) Description and Business Overview Table 189. Zhejiang Huahai Pharmaceutical (CN) Lexapro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 190. Zhejiang Huahai Pharmaceutical (CN) Product Table 191. Zhejiang Huahai Pharmaceutical (CN) Recent Development Table 192. Lexapro Market Trends Table 193. Lexapro Market Drivers Table 194. Lexapro Market Challenges Table 195. Lexapro Market Restraints Table 196. Lexapro Customers List Table 197. Lexapro Distributors List Table 198. Research Programs/Design for This Report Table 199. Key Data Information from Secondary Sources Table 200. Key Data Information from Primary Sources List of Figures Figure 1. Lexapro Product Picture Figure 2. Global Lexapro Sales Market Share by Type in 2020 & 2027 Figure 3. Tablets Product Picture Figure 4. Solution Product Picture Figure 5. Global Lexapro Sales Market Share by Application in 2020 & 2027 Figure 6. Children Figure 7. Adults Figure 8. Lexapro Report Years Considered Figure 9. Global Lexapro Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Lexapro Market Size 2016-2027 (US$ Million) Figure 11. Global Lexapro Sales 2016-2027 (K Units) Figure 12. Global Lexapro Market Size Market Share by Region: 2021 Versus 2027 Figure 13. Global Lexapro Sales Market Share by Region (2016-2021) Figure 14. Global Lexapro Sales Market Share by Region in 2020 Figure 15. Global Lexapro Revenue Market Share by Region (2016-2021) Figure 16. Global Lexapro Revenue Market Share by Region in 2020 Figure 17. Global Lexapro Sales Share by Manufacturer in 2020 Figure 18. The Top 10 and 5 Players Market Share by Lexapro Revenue in 2020 Figure 19. Lexapro Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Lexapro Sales Market Share by Type (2016-2021) Figure 21. Global Lexapro Sales Market Share by Type in 2020 Figure 22. Global Lexapro Revenue Market Share by Type (2016-2021) Figure 23. Global Lexapro Revenue Market Share by Type in 2020 Figure 24. Global Lexapro Sales Market Share by Application (2016-2021) Figure 25. Global Lexapro Sales Market Share by Application in 2020 Figure 26. Global Lexapro Revenue Market Share by Application (2016-2021) Figure 27. Global Lexapro Revenue Market Share by Application in 2020 Figure 28. Japan Lexapro Sales Growth Rate 2016-2027 (K Units) Figure 29. Japan Lexapro Revenue Growth Rate 2016-2027 (US$ Million) Figure 30. Japan Lexapro Market Share in Global Market 2016-2027 Figure 31. Japan 5 and 10 Largest Lexapro Players Market Share by Revenue in Lexapro in 2020 Figure 32. Japan Lexapro Revenue Share by Type (2016-2021) Figure 33. Japan Lexapro Revenue Growth Rate by Type in 2016 & 2020 Figure 34. Japan Lexapro Revenue Share by Application (2016-2021) Figure 35. Japan Lexapro Revenue Growth Rate by Application in 2016 & 2020 Figure 36. North America Lexapro Sales Growth Rate 2016-2021 (K Units) Figure 37. North America Lexapro Revenue Growth Rate 2016-2021 (US$ Million) Figure 38. North America Lexapro Sales Market Share by Country in 2020 Figure 39. North America Lexapro Revenue Market Share by Country in 2020 Figure 40. United States Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 41. United States Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Canada Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 43. Canada Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Europe Lexapro Sales Growth Rate 2016-2021 (K Units) Figure 45. Europe Lexapro Revenue Growth Rate 2016-2021 (US$ Million) Figure 46. Europe Lexapro Sales Market Share by Country in 2020 Figure 47. Europe Lexapro Revenue Market Share by Country in 2020 Figure 48. Germany Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 49. Germany Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. France Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 51. France Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. U.K. Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 53. U.K. Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. Italy Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 55. Italy Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Russia Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 57. Russia Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Asia Pacific Lexapro Sales Growth Rate 2016-2021 (K Units) Figure 59. Asia Pacific Lexapro Revenue Growth Rate 2016-2021 (US$ Million) Figure 60. Asia Pacific Lexapro Sales Market Share by Region in 2020 Figure 61. Asia Pacific Lexapro Revenue Market Share by Region in 2020 Figure 62. China Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 63. China Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Japan Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 65. Japan Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. South Korea Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 67. South Korea Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. India Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 69. India Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. Australia Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 71. Australia Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. China Taiwan Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 73. China Taiwan Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Indonesia Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 75. Indonesia Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Thailand Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 77. Thailand Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Malaysia Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 79. Malaysia Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Latin America Lexapro Sales Growth Rate 2016-2021 (K Units) Figure 81. Latin America Lexapro Revenue Growth Rate 2016-2021 (US$ Million) Figure 82. Latin America Lexapro Sales Market Share by Country in 2020 Figure 83. Latin America Lexapro Revenue Market Share by Country in 2020 Figure 84. Mexico Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 85. Mexico Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Brazil Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 87. Brazil Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 88. Argentina Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 89. Argentina Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Middle East and Africa Lexapro Sales Growth Rate 2016-2021 (K Units) Figure 91. Middle East and Africa Lexapro Revenue Growth Rate 2016-2021 (US$ Million) Figure 92. Middle East and Africa Lexapro Sales Market Share by Country in 2020 Figure 93. Middle East and Africa Lexapro Revenue Market Share by Country in 2020 Figure 94. Turkey Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 95. Turkey Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Saudi Arabia Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 97. Saudi Arabia Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 98. UAE Lexapro Sales Growth Rate (2016-2021) (K Units) Figure 99. UAE Lexapro Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Lexapro Value Chain Figure 101. Channels of Distribution Figure 102. Distributors Profiles Figure 103. Bottom-up and Top-down Approaches for This Report Figure 104. Data Triangulation Figure 105. Key Executives Interviewed

Lundbeck (DK) Amneal Pharmaceuticals (US) Forest Laboratories (US) TEVA (Israel) Mylan (US) Silarx Pharmacueticals (US) Apotex (CA) Lupin (IN) Novartis (US) Hikma Pharmaceuticals (UK) Aurobindo Pharma (IN) Hetero Drugs (IN) Accord Healthcare (IN) Macleods Pharmaceuticals (IN) Xian Janssen Pharmaceutical (CN) Jewim Pharmaceutical (Shandong) Sichuan Kelun Pharmaceutical (CN) Hunan Dongting Pharmaceutical (CN) Zhejiang Conba Pharmaceutical (CN) Xidian Pharmaceutical (CN) Zhejiang Huahai Pharmaceutical (CN)